Informações de IDEXX Laboratories Inc

Mais detalhes de IDEXX Laboratories Inc Empresa

IDEXX Laboratories, Inc. develops, manufactures and distributes products and provides services primarily for the companion animal veterinary, livestock and poultry, dairy and water testing industries. The Company also provides human medical point-of-care and laboratory diagnostics. Its segments include Companion Animal Group (CAG), Water quality products (Water), and Livestock, Poultry and Dairy (LPD). The CAG segment offers diagnostic and information management-based products and services for the companion animal veterinary industry, including in-clinic diagnostic solutions, outside reference laboratory services, and veterinary software and services. Its Water segment provides testing solutions for accurate detection and quantification of various microbiological parameters in water. Its LPD segment provides diagnostic tests, services, and related instrumentation that are used to manage the health status of livestock and poultry, to improve the quality and safety of milk.



Código da empresaIDXX

Nome da EmpresaIDEXX Laboratories Inc

Data de listagemJun 21, 1991

CEOMr. Andrew Emerson

Número de funcionários11000

Tipo de títulosOrdinary Share

Fim do ano fiscalJun 21

EndereçoOne Idexx Drive

CidadeWESTBROOK

Bolsa de valoresNASDAQ Global Select Consolidated

PaísUnited States of America

Código postal04092-2041

Telefone12075560300

Sitehttps://www.idexx.com/

Código da empresaIDXX

Data de listagemJun 21, 1991

CEOMr. Andrew Emerson

Executivos da empresa IDEXX Laboratories Inc



Nome

Nome/Posição

Posição

Ações detidas

Variação

Mr. Michael Erickson, Ph.D.

Executive Vice President and General Manager, Point of Care Diagnostics and Telemedicine

12.58K

+18.05%

Dr. Sophie V. Vandebroek, Ph.D.

Independent Director

8.69K

+3.11%

Mr. Lawrence D. (Larry) Kingsley

Independent Chairman of the Board

8.23K

+4.39%

Mr. Michael J. Lane

Executive Vice President and General Manager, Global Reference Laboratories, Diagnostic Solutions and Information Technology

7.70K

--

Ms. Sharon E. Underberg

Executive Vice President, General Counsel, Corporate Secretary

6.12K

+3.08%

Mr. Andrew Emerson

Executive Vice President, Chief Executive Officer, Treasurer

3.84K

+60.39%

Mr. Daniel M. (Dan) Junius

Independent Director

3.00K

+9.56%

Mr. Michael Schreck

Executive Vice President and General Manager, Veterinary Software and Services, Corporate Accounts and Customer Experience

1.92K

+112.86%

Mr. Bruce L. Claflin

Independent Director

1.72K

--

Dr. Stuart M. Essig, Ph.D.

Independent Director

1.09K

+31.76%

Ver Mais

Nome

Nome/Posição

Posição

Ações detidas

Variação

Mr. Michael Erickson, Ph.D.

Executive Vice President and General Manager, Point of Care Diagnostics and Telemedicine

12.58K

+18.05%

Dr. Sophie V. Vandebroek, Ph.D.

Independent Director

8.69K

+3.11%

Mr. Lawrence D. (Larry) Kingsley

Independent Chairman of the Board

8.23K

+4.39%

Mr. Michael J. Lane

Executive Vice President and General Manager, Global Reference Laboratories, Diagnostic Solutions and Information Technology

7.70K

--

Ms. Sharon E. Underberg

Executive Vice President, General Counsel, Corporate Secretary

6.12K

+3.08%

Mr. Andrew Emerson

Executive Vice President, Chief Executive Officer, Treasurer

3.84K

+60.39%

Detalhamento da receita

Moeda: USDAtualizado em: seg, 6 de out

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

FY2018

Por EmpresaUSD

Nome

Receita

Proporção

CAG Diagnostics recurring revenue

878.00M

79.14%

IDEXX VetLab consumables

375.11M

33.81%

Reference laboratory diagnostic and consulting services

367.69M

33.14%

Rapid assay products

100.24M

9.04%

CAG Diagnostics capital - instruments

85.85M

7.74%

Outro

-697.43M

-62.86%

Por RegiãoUSD

Nome

Receita

Proporção

United States

717.87M

64.70%

Europe & Middle East & Africa (EMEA) (Region)

233.27M

21.03%

Asia Pacific

89.30M

8.05%

Canada

46.69M

4.21%

Latin America

22.33M

2.01%

Por Empresa

Por Região

Por EmpresaUSD

Nome

Receita

Proporção

CAG Diagnostics recurring revenue

878.00M

79.14%

IDEXX VetLab consumables

375.11M

33.81%

Reference laboratory diagnostic and consulting services

367.69M

33.14%

Rapid assay products

100.24M

9.04%

CAG Diagnostics capital - instruments

85.85M

7.74%

Outro

-697.43M

-62.86%

Distribuição de ações

Atualizado em: ter, 19 de ago

Investidores

Tipos de investidores

Investidores

Proporção

The Vanguard Group, Inc.

12.43%

BlackRock Institutional Trust Company, N.A.

6.64%

State Street Investment Management (US)

4.45%

Fundsmith LLP

3.31%

Geode Capital Management, L.L.C.

3.09%

Outro

70.09%

Investidores

Proporção

The Vanguard Group, Inc.

12.43%

BlackRock Institutional Trust Company, N.A.

6.64%

State Street Investment Management (US)

4.45%

Fundsmith LLP

3.31%

Geode Capital Management, L.L.C.

3.09%

Outro

70.09%

Tipos de investidores

Investidores

Proporção

Investment Advisor

54.21%

Investment Advisor/Hedge Fund

32.64%

Research Firm

4.10%

Pension Fund

2.59%

Bank and Trust

2.03%

Hedge Fund

0.91%

Individual Investor

0.69%

Sovereign Wealth Fund

0.61%

Family Office

0.50%

Outro

1.72%

Participação acionária institucional



Atualizado em: qua, 1 de out

Período do relatório

N.º de instituições

Ações detidas

Proporção

Variação

2025Q3

2319

77.76M

97.19%

-4.03M

2025Q2

2277

79.81M

99.73%

-1.01M

2025Q1

2279

79.02M

98.21%

-512.23K

2024Q4

2242

76.14M

93.59%

-5.30M

2024Q3

2152

77.90M

94.66%

-4.67M

2024Q2

2140

80.09M

96.98%

-924.14K

2024Q1

2154

77.56M

93.40%

-2.57M

2023Q4

2187

77.94M

93.84%

-2.83M

2023Q3

2153

79.23M

95.34%

-677.16K

2023Q2

2157

77.53M

93.40%

-1.56M

Ver Mais

Atividade dos acionistas



Nome

Ações detidas

Proporção

Variação

Var. %

Data

The Vanguard Group, Inc.

9.84M

12.3%

+19.20K

+0.20%

Jun 30, 2025

BlackRock Institutional Trust Company, N.A.

5.30M

6.63%

-132.86K

-2.44%

Jun 30, 2025

State Street Investment Management (US)

3.55M

4.44%

-95.45K

-2.62%

Jun 30, 2025

Fundsmith LLP

2.64M

3.3%

-9.04K

-0.34%

Jun 30, 2025

Geode Capital Management, L.L.C.

2.46M

3.08%

+54.40K

+2.26%

Jun 30, 2025

Baron Capital Management, Inc.

2.03M

2.54%

-27.16K

-1.32%

Jun 30, 2025

Invesco Capital Management (QQQ Trust)

1.65M

2.06%

-5.80K

-0.35%

Aug 31, 2025

Principal Global Investors (Equity)

1.13M

1.41%

+1.75K

+0.16%

Jun 30, 2025

Polen Capital Management, LLC

1.20M

1.49%

+1.12M

+1519.07%

Jun 30, 2025

Walter Scott & Partners Ltd.

756.69K

0.95%

+597.11K

+374.18%

Jun 30, 2025

Ver Mais

ETFs Relacionados



Atualizado em: qui, 6 de nov

Nome

Proporção

ProShares Pet Care ETF

10%

SMI 3Fourteen Full-Cycle Trend ETF

5.05%

iShares U.S. Medical Devices ETF

4.57%

First Trust Water ETF

4%

Hennessy Sustainable ETF

3.65%

Nuveen ESG Mid-Cap Growth ETF

3.52%

Innovator IBD Breakout Opportunities ETF

2.77%

Adaptive Core ETF

2.61%

Tema Durable Quality ETF

2.47%

First Trust S&P 500 Economic Moat Index ETF

2.34%

Ver Mais

ProShares Pet Care ETF

Proporção10%

SMI 3Fourteen Full-Cycle Trend ETF

Proporção5.05%

iShares U.S. Medical Devices ETF

Proporção4.57%

First Trust Water ETF

Proporção4%

Hennessy Sustainable ETF

Proporção3.65%

Nuveen ESG Mid-Cap Growth ETF

Proporção3.52%

Innovator IBD Breakout Opportunities ETF

Proporção2.77%

Adaptive Core ETF

Proporção2.61%

Tema Durable Quality ETF

Proporção2.47%

First Trust S&P 500 Economic Moat Index ETF

Proporção2.34%

Dividendo



Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.

Data

Dividendo

Data de registro

Data de pagamento

Data ex-dividendo

Sem dados

Desdobramento de ações



Data

Tipo

Proporção

Sem dados

Data

Tipo

Proporção

Sem dados